Literature DB >> 20714875

Expression of angiotensin II receptors in aldosterone-producing adenoma of the adrenal gland and their clinical significance.

Zhun Wu1, Dong Ni, Yongji Yan, Jun Li, Baojun Wang, Jinzhi Ouyang, Guoxi Zhang, Xin Ma, Hongzhao Li, Xu Zhang.   

Abstract

The expression of angiotensin II type 1 receptor (AT1R) and angiotensin II type 2 receptor (AT2R) in aldosterone-producing adenoma (APA) of the adrenal gland was detected, and their relationship with clinical indexes of APA was analyzed. The mRNA expression of AT1R and AT2R in 50 cases of APA and tissues adjacent to tumors and 12 cases of normal adrenal tissues was detected by using reverse transcriptase polymerase chain reaction (RT-PCR). The expression of AT1R and AT2R proteins in paraffin-embedded slices of tissue was detected by immunohistochemistry. The expression of AT1R in adenoma, tissues adjacent to tumor, and normal tissues of the adrenal gland showed no significant differences. The expression of AT2R in APA tissue was lower than that in normal adrenal gland tissues (P<0.05). Correlation analysis of the mRNA expression level of AT2R and clinical data from patients demonstrated that AT2R expression was negatively related to plasma aldosterone concentration (PAC) (r=-0.467, P<0.05), but positively related with plasma renin activity (PRA) (r=0.604, P<0.05). It is concluded that down-regulation of the AT2R expression is possibly related with the tumorigenesis of APA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20714875     DOI: 10.1007/s11596-010-0454-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  19 in total

Review 1.  Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.

Authors:  M Ehrhart-Bornstein; J P Hinson; S R Bornstein; W A Scherbaum; G P Vinson
Journal:  Endocr Rev       Date:  1998-04       Impact factor: 19.871

Review 2.  Mineralocorticoid hypertension.

Authors:  P M Stewart
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

3.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors:  Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

4.  Adrenal sensitivity to angiotensin II and undiscovered aldosterone stimulating factors in hypertension.

Authors:  R D Brown; M Wisgerhof; P C Carpenter; G Brown; N S Jiang; P Kao; R Hegstad
Journal:  J Steroid Biochem       Date:  1979-07       Impact factor: 4.292

Review 5.  International union of pharmacology. XXIII. The angiotensin II receptors.

Authors:  M de Gasparo; K J Catt; T Inagami; J W Wright; T Unger
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

6.  Angiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20.

Authors:  Gunter Wolf; Sigrid Harendza; Regine Schroeder; Ulrich Wenzel; Gunther Zahner; Ulrike Butzmann; Robert S Freeman; Rolf A K Stahl
Journal:  Lab Invest       Date:  2002-10       Impact factor: 5.662

7.  Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms.

Authors:  B Schubert; M Fassnacht; F Beuschlein; S Zenkert; B Allolio; M Reincke
Journal:  Clin Endocrinol (Oxf)       Date:  2001-05       Impact factor: 3.478

8.  Immunohistochemical detection of angiotensin receptors AT1 and AT2 in adrenal tumors.

Authors:  Marek Pawlikowski; Katarzyna Winczyk; Beata Sledź
Journal:  Folia Histochem Cytobiol       Date:  2008       Impact factor: 1.698

9.  Expression of AT2 receptors in the developing rat fetus.

Authors:  E F Grady; L A Sechi; C A Griffin; M Schambelan; J E Kalinyak
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Type 1 angiotensin II receptors of adrenal tumors.

Authors:  H Nawata; R Takayanagi; K Ohnaka; Y Sakai; K Imasaki; T Yanase; S Ikuyama; S Tanaka; K Ohe
Journal:  Steroids       Date:  1995-01       Impact factor: 2.668

View more
  2 in total

1.  Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.

Authors:  Wei-Guo Chen; Ting-Ting Zhou; Peng Zhou; Xiao-Wei Li; Zhun Wu; Kai-Yan Zhang; Jin-Chun Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Association of polymorphisms in angiotensin II receptor genes with aldosterone-producing adenoma.

Authors:  Jinzhi Ouyang; Zhun Wu; Jinchun Xing; Yongji Yan; Guoxi Zhang; Baojun Wang; Hongzhao Li; Xin Ma; Xu Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.